ClinicalTrials.Veeva

Find clinical trials for COVID-19 in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Syndrome
Human Influenza
Post-Acute COVID-19 Syndrome

COVID-19 trials near Kansas City, KS, USA:

A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. (COVID-19)

vaccine (SARS-CoV-2 rS) adjuvanted with Matrix-M™ in previously mRNA COVID-19 vaccinated adult participants ≥18 years of age and ba-...

Active, not recruiting
COVID-19
Biological: XBB.1.5 Vaccine (single dose)
Biological: XBB.1.5 Vaccine (Booster)

Phase 2, Phase 3

Novavax
Novavax

Kansas City, Missouri, United States and 29 other locations

Accordingly, ESRD patients are particularly susceptible to COVID-19 infection. Ta1 has been shown to be safely administered to hemo...

Active, not recruiting
COVID-19
Drug: Thymalfasin

Phase 2

William B. Ershler, MD

Kansas City, Missouri, United States of America

multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and severe symptoms of COVID...

Invitation-only
Covid19
Corona Virus Infection
Drug: Ebselen
Drug: Placebo

Phase 2

Sound Pharmaceuticals

Kansas City, Kansas, United States and 6 other locations

multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and moderate symptoms of COVID...

Invitation-only
Covid19
Corona Virus Infection
Drug: Ebselen
Drug: Placebo

Phase 2

Sound Pharmaceuticals

Kansas City, Kansas, United States and 6 other locations

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
COVID-19
Biological: mRNA-1273.222
Biological: mRNA-1283.222

Phase 3

Moderna
Moderna

Kansas City, Missouri, United States and 217 other locations

stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID...

Enrolling
COVID-19
Device: RD-X19
Device: Sham
EmitBio

Kansas City, Missouri, United States and 47 other locations

This is an exploratory Phase I, randomized, observer-blind, active-controlled, dose-escalation trial to evaluate four dose levels (DLs) of BNT162b4 g...

Active, not recruiting
COVID-19
SARS-CoV-2 Infection
Biological: BNT162b4 30 µg
Biological: BNT162b4 15 µg

Phase 1

BioNTech
BioNTech

Kansas City, Missouri, United States and 16 other locations

concomitant development of persistent fibrotic lung damage. This study intends to evaluate benefits of a combination of VL-P22 and VL-PX10 in Covid...

Enrolling
COVID-19 Respiratory Infection
Pulmonary Fibrosis
Drug: Placebo
Drug: VL-PX10 and VL-P22 plus standard care

Phase 2

Vitti Labs

Liberty, Missouri, United States

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Fairway, Kansas, United States and 59 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Parent study Main Cohort)
Biological: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Kansas City, Missouri, United States and 214 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems